Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
AGB-Pharma AB
AB
Active
Org 5568592074
Lund
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2011 · 15 years old
20-49 employees
Monitor
Share
Sweden
/
Companies
/
Manufacture of pharmaceutical preparations
/
AGB-Pharma AB
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (2)
KE
Karin Elisabeth Ruth Hesselgard
External Signatory
External Signatory
2024
CA
Curt Arne Jesper Ahlkvist
Audit
Audit
2021
Former (2)
BF
Björn Fredrik Lindberg
Chief Executive Officer
Chief Executive Officer
2020 – 2024
SS
Stig Sven Gunnar Henningsson
Chief Executive Officer
Chief Executive Officer
2019 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
UA
Ulla Anne-Charlotte Henningsson
Board of Directors
Board of Directors
2021
SS
Stig Sven Gunnar Henningsson
Board of Directors
Board of Directors
2019
NP
Nils Pontus Larsson Bergman
Chairman
Chairman
2021
Former (1)
EH
Emilie Helena Tammelin
Deputy Board Member
Deputy Board Member
2021 – 2022
Shareholders
As of last annual report
S Development AB — 100%
100%
Shareholder
Type
Ownership
Votes
Since
S Development AB
Company
100%
100%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on AGB-Pharma AB
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network